Translation initiation factor 4E (eIF4E): Prognostic marker and potential therapeutic target

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 2296-2297

  Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INITIATION FACTOR 4E; PROTEIN KINASE B; RAPAMYCIN; TEMSIROLIMUS;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DRUG MECHANISM; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; WESTERN BLOTTING;

EID: 55149115382     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0116-7     Document Type: Editorial

References (13)

1. F Meric KK Hunt 2002 Translation initiation in cancer: a novel target for therapy Mol Cancer Ther 1 971 9
2. S Li T Takasu DM Perlman 2003 Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release J Biol Chem 278 3015 22
3. A De Benedetti RE Rhoads 1990 Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology Proc Natl Acad Sci USA 87 8212 6
4. DC Fingar S Salama C Tsou 2002 Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes Dev 16 1472 87
5. Holm N, Byrnes K, Johnson L, et al. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer. Ann Surg Oncol. (in press)
6. O Larsson S Li OA Issaenko 2007 Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors Cancer Res 67 6814 24
7. K Byrnes S White Q Chu 2006 High eIF4E, VEGF, and microvessel density in stage I to III breast cancer Ann Surg 243 684 90 discussion 691-2
8. BD Li L Liu M Dawson 1997 Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma Cancer 79 2385 90
9. JR Graff BW Konicek TM Vincent 2007 Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity J Clin Invest 117 2638 48
10. A Soni A Akcakanat G Singh 2008 eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling Mol Cancer Ther 7 1782 8
11. B Culjkovic K Tan S Orolicki 2008 The eIF4E RNA regulon promotes the Akt signaling pathway J Cell Biol 181 51 63
12. CA Nathan P Carter L Liu 1997 Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas Oncogene 15 1087 94
13. L Beretta AC Gingras YV Svitkin 1996 Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation EMBO J 15 658 64